Case Report: Facial Malassezia folliculitis following infliximab treatment in Crohn’s disease

Case Report: Facial Malassezia folliculitis following infliximab treatment in Crohn’s disease

Infliximab (IFX), a first-line treatment for moderate to severe Crohn’s disease (CD), has immunomodulatory effects that increase the risk of opportunistic infections. Although IFX-associated invasive fungal infections have received widespread attention, IFX-associated superficial cutaneous fungal in...

Full description

Saved in:
Bibliographic Details
Main Authors: Liji Chen, Yanyan Ma, Shaoyu Cheng, Beiping Zhang, Tianwen Liu, Xiying Zhao
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-08-01
Series:Frontiers in Immunology
Subjects:
inflammatory bowel disease
Crohn’s disease
infliximab
Malassezia folliculitis
adverse event
fungal infection
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1611893/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items